首页> 中文期刊> 《陕西医学杂志》 >LTS液基细胞学联合HPV16/18检测筛查早期宫颈癌的价值

LTS液基细胞学联合HPV16/18检测筛查早期宫颈癌的价值

             

摘要

Objective > Explore the LTS liquid based cytology producer joint liquid based residual liquid HPV16/18 cervical cancer screening lesion before value of clinical application. Method t Using the LTS liquid based cells producer method to detect 1000 cases of patients with the mouth and obstetrics and gynecology cervical neck tube exfoliated cells and discharge,the remaining liquid based cells remain fluid HPV16/18 immune markmethod to detect. HPV16/18 positive and highly suspected patients with cervical lesions vaginal microscopically more biopsy, combined with the pathologic result analysis cervical lesions. Results: 1000 cases of sample analysis by the LTS detection in 870, 24 cases of ASCUS ASCUS-H 26 cases, LSIL 61 cases, H SIL 19 cases. 130 cases of vaginal cytology unusual person under mirror more tissue biopsies confirmed 71 cases of inflammatory, CINI18 example, CINII 21 example, CINIII 13 cases, invasive cancer in 3, 4 cases were wet wart. Immune markmethod to detect DNA found HPV16/18 infection rates for: normal or inflammation respectively 21. 1%, CINI16. 7 %, CINII 33. 3%, CINIII 69.2%, invasive cancer, wet wart 40.0% 100%. 65 cases of normal, HPV16/18 LTS positive patients with pathological test showed that inflammation 51 cases, CINI (19 cases), CINII5 cases. The LTS normal or inflammation and HPV16/18 positive patients with cervical lesions, the detection rate of 21. 5%. Conclusion: Liquid based cytology producer joint liquid based residual liquid HPV16 /18 cells detection can add cytology results, the screening early cer ical cancer to have the important meaning.%目的:探讨LTS液基细胞学联合液基细胞残留液HPV16/18检测筛查宫颈癌前病变的临床应用价值.方法:采用LTS液基细胞制片法检测1000例患者宫颈外口及颈管脱落细胞和分泌物,将剩余液基细胞残留液进行HPV16/18免疫印记法检测.HPV16/18阳性且高度怀疑宫颈病变患者进行阴道镜下多点活检,结合病理结果分析宫颈病变.结果:1000例样本经LTS检测正常者870例,ASCUS 24例,ASCUS-H 26例,LSIL 61例,HSIL 19例.130例细胞学异常者阴道镜下多点组织活检证实炎症71例,CINI 18例,CINII 21例,CI NIII 13例,浸润癌2例,湿疣5例.免疫印记法检测HPVDNA发现HPV16/18感染率分别为:正常或炎症21.1%,CINI 16.7%,CINII 33.3%,CINIII 69.2%,浸润癌100%,湿疣40.0%.65例LTS正常,HPV16/18阳性患者病理检测显示炎症51例,CINI 19例,CINII 5例.LTS正常或炎症和HPV16/18阳性患者中,宫颈病变的检出率为21.5%.结论:液基细胞学制片联合液基细胞残留液HPV16/18检测可以补充细胞学检查结果,对筛查早期宫颈癌有重要意义.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号